| 000 | 01733 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514074633.0 | ||
| 264 | 0 | _c20040128 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0893-133X | ||
| 024 | 7 |
_a10.1038/sj.npp.1300251 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGreenwald, Mark K | |
| 245 | 0 | 0 |
_aEffects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. _h[electronic resource] |
| 260 |
_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cNov 2003 |
||
| 300 |
_a2000-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBuprenorphine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeroin Dependence _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Opioid, mu _xagonists |
| 650 | 0 | 4 |
_aTomography, Emission-Computed _xmethods |
| 700 | 1 | _aJohanson, Chris-Ellyn | |
| 700 | 1 | _aMoody, David E | |
| 700 | 1 | _aWoods, James H | |
| 700 | 1 | _aKilbourn, Michael R | |
| 700 | 1 | _aKoeppe, Robert A | |
| 700 | 1 | _aSchuster, Charles R | |
| 700 | 1 | _aZubieta, Jon-Kar | |
| 773 | 0 |
_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 28 _gno. 11 _gp. 2000-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.npp.1300251 _zAvailable from publisher's website |
| 999 |
_c12677988 _d12677988 |
||